Alirocumab and Plaque Burden In Familial Hypercholesterolaemia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT05465278
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 104 participants
- Sponsor
- Fundación Hipercolesterolemia Familiar
- Registry
-
NCT05465278
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT05465278. Allocation not applicable; no masking; primary purpose treatment. Start 2018-05-01 (actual); primary completion 2022-03-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Alirocumab and Plaque Burden In Familial Hypercholesterolaemia
- Acronym
- ARCHITECT
- Condition
- Familial Hypercholesterolemia
- Intervention (Drug)
- Alirocumab
- Lead sponsor
- Fundación Hipercolesterolemia Familiar
Record details
- Record id
cardio:ct-nct05465278- Content hash
8dda07eb72e1bce68ec281b9568d381f07e311636749606f27db68d55bf28b62